Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-19

Clinical Trial Update: Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether abatacept can prevent rheumatoid arthritis in adult patients at risk, compared with placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2009-11-19